nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS1—esophageal cancer	0.506	0.636	CbGaD
Magnesium salicylate—PTGS2—esophageal cancer	0.289	0.364	CbGaD
Magnesium salicylate—PTGS2—Cisplatin—esophageal cancer	0.0914	0.709	CbGbCtD
Magnesium salicylate—ALB—Methotrexate—esophageal cancer	0.0374	0.29	CbGbCtD
Magnesium salicylate—Trisalicylate-choline—PTGS1—esophageal cancer	0.00139	0.185	CrCbGaD
Magnesium salicylate—Localized exfoliation—Capecitabine—esophageal cancer	0.00118	0.0754	CcSEcCtD
Magnesium salicylate—Salicylate-sodium—PTGS1—esophageal cancer	0.000844	0.112	CrCbGaD
Magnesium salicylate—Trisalicylate-choline—PTGS2—esophageal cancer	0.000796	0.106	CrCbGaD
Magnesium salicylate—Nepafenac—PTGS1—esophageal cancer	0.000592	0.0784	CrCbGaD
Magnesium salicylate—Olsalazine—PTGS1—esophageal cancer	0.000578	0.0767	CrCbGaD
Magnesium salicylate—Gastric ulcer—Capecitabine—esophageal cancer	0.000547	0.0349	CcSEcCtD
Magnesium salicylate—Salsalate—PTGS1—esophageal cancer	0.000492	0.0652	CrCbGaD
Magnesium salicylate—Salicylate-sodium—PTGS2—esophageal cancer	0.000482	0.0639	CrCbGaD
Magnesium salicylate—Hearing impaired—Cisplatin—esophageal cancer	0.000453	0.0289	CcSEcCtD
Magnesium salicylate—Pain—Carboplatin—esophageal cancer	0.000449	0.0287	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Cisplatin—esophageal cancer	0.000412	0.0263	CcSEcCtD
Magnesium salicylate—Deafness—Cisplatin—esophageal cancer	0.00035	0.0224	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Capecitabine—esophageal cancer	0.000347	0.0222	CcSEcCtD
Magnesium salicylate—Burning sensation—Methotrexate—esophageal cancer	0.000341	0.0218	CcSEcCtD
Magnesium salicylate—Nepafenac—PTGS2—esophageal cancer	0.000338	0.0448	CrCbGaD
Magnesium salicylate—Hearing impaired—Capecitabine—esophageal cancer	0.000334	0.0213	CcSEcCtD
Magnesium salicylate—Olsalazine—PTGS2—esophageal cancer	0.00033	0.0438	CrCbGaD
Magnesium salicylate—Stupor—Methotrexate—esophageal cancer	0.000317	0.0202	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Capecitabine—esophageal cancer	0.000307	0.0196	CcSEcCtD
Magnesium salicylate—Carbamazepine—ABCC2—esophageal cancer	0.000307	0.0407	CrCbGaD
Magnesium salicylate—Skin exfoliation—Capecitabine—esophageal cancer	0.000304	0.0194	CcSEcCtD
Magnesium salicylate—Salicylic acid—PTGS1—esophageal cancer	0.000302	0.0401	CrCbGaD
Magnesium salicylate—Oesophagitis—Capecitabine—esophageal cancer	0.000291	0.0186	CcSEcCtD
Magnesium salicylate—Ecchymosis—Capecitabine—esophageal cancer	0.000288	0.0184	CcSEcCtD
Magnesium salicylate—Salsalate—PTGS2—esophageal cancer	0.000281	0.0373	CrCbGaD
Magnesium salicylate—Abdominal discomfort—Cisplatin—esophageal cancer	0.000259	0.0166	CcSEcCtD
Magnesium salicylate—Deafness—Capecitabine—esophageal cancer	0.000258	0.0165	CcSEcCtD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—PTGS1—esophageal cancer	0.000246	0.00472	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.000246	0.00472	CbGpPWpGaD
Magnesium salicylate—Ketoprofen—PTGS1—esophageal cancer	0.00024	0.0318	CrCbGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—LGALS3—esophageal cancer	0.000237	0.00454	CbGpPWpGaD
Magnesium salicylate—Lethargy—Capecitabine—esophageal cancer	0.000236	0.015	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Methotrexate—esophageal cancer	0.000229	0.0146	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Methotrexate—esophageal cancer	0.000226	0.0144	CcSEcCtD
Magnesium salicylate—Ecchymosis—Methotrexate—esophageal cancer	0.000214	0.0137	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000211	0.00406	CbGpPWpGaD
Magnesium salicylate—Abdominal pain upper—Capecitabine—esophageal cancer	0.000211	0.0135	CcSEcCtD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—SOD2—esophageal cancer	0.00021	0.00403	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—HSPA5—esophageal cancer	0.00021	0.00403	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CXCL2—esophageal cancer	0.000205	0.00394	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—ALDH2—esophageal cancer	0.000203	0.00391	CbGpPWpGaD
Magnesium salicylate—Tinnitus—Cisplatin—esophageal cancer	0.000202	0.0129	CcSEcCtD
Magnesium salicylate—Flushing—Cisplatin—esophageal cancer	0.000201	0.0128	CcSEcCtD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—esophageal cancer	0.0002	0.00383	CbGpPWpGaD
Magnesium salicylate—Asthma—Capecitabine—esophageal cancer	0.0002	0.0127	CcSEcCtD
Magnesium salicylate—ALB—Selenium Micronutrient Network—PTGS1—esophageal cancer	0.000199	0.00382	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—GSTT1—esophageal cancer	0.000193	0.00371	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.000193	0.0037	CbGpPWpGaD
Magnesium salicylate—Abdominal discomfort—Capecitabine—esophageal cancer	0.000191	0.0122	CcSEcCtD
Magnesium salicylate—PTGS1—Biological oxidations—CYP2A6—esophageal cancer	0.000191	0.00367	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000191	0.00367	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—ANXA1—esophageal cancer	0.000191	0.00366	CbGpPWpGaD
Magnesium salicylate—Erythema—Cisplatin—esophageal cancer	0.000189	0.012	CcSEcCtD
Magnesium salicylate—PTGS1—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000187	0.00358	CbGpPWpGaD
Magnesium salicylate—Weight increased—Capecitabine—esophageal cancer	0.000182	0.0116	CcSEcCtD
Magnesium salicylate—Lethargy—Methotrexate—esophageal cancer	0.000175	0.0112	CcSEcCtD
Magnesium salicylate—Salicylic acid—PTGS2—esophageal cancer	0.000173	0.0229	CrCbGaD
Magnesium salicylate—ALB—Folate Metabolism—SOD2—esophageal cancer	0.000171	0.00328	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000168	0.00322	CbGpPWpGaD
Magnesium salicylate—Epistaxis—Capecitabine—esophageal cancer	0.000168	0.0107	CcSEcCtD
Magnesium salicylate—Hepatitis—Capecitabine—esophageal cancer	0.00016	0.0102	CcSEcCtD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000159	0.00306	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—CYP1B1—esophageal cancer	0.000154	0.00296	CbGpPWpGaD
Magnesium salicylate—Oedema—Cisplatin—esophageal cancer	0.000154	0.00983	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Capecitabine—esophageal cancer	0.000151	0.00964	CcSEcCtD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PFN1—esophageal cancer	0.000149	0.00287	CbGpPWpGaD
Magnesium salicylate—Tinnitus—Capecitabine—esophageal cancer	0.000149	0.00951	CcSEcCtD
Magnesium salicylate—ALB—Hemostasis—CAPZA1—esophageal cancer	0.000149	0.00286	CbGpPWpGaD
Magnesium salicylate—Hyperhidrosis—Cisplatin—esophageal cancer	0.000149	0.0095	CcSEcCtD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000149	0.00285	CbGpPWpGaD
Magnesium salicylate—Asthma—Methotrexate—esophageal cancer	0.000149	0.00948	CcSEcCtD
Magnesium salicylate—Flushing—Capecitabine—esophageal cancer	0.000148	0.00946	CcSEcCtD
Magnesium salicylate—Salicylic acid—ABCB1—esophageal cancer	0.000147	0.0195	CrCbGaD
Magnesium salicylate—Anorexia—Cisplatin—esophageal cancer	0.000147	0.00937	CcSEcCtD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000146	0.0028	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—CYP19A1—esophageal cancer	0.000145	0.00278	CbGpPWpGaD
Magnesium salicylate—Hypotension—Cisplatin—esophageal cancer	0.000144	0.00918	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Methotrexate—esophageal cancer	0.000142	0.00909	CcSEcCtD
Magnesium salicylate—Erythema—Capecitabine—esophageal cancer	0.000139	0.00888	CcSEcCtD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000138	0.00266	CbGpPWpGaD
Magnesium salicylate—Ketoprofen—PTGS2—esophageal cancer	0.000137	0.0182	CrCbGaD
Magnesium salicylate—Dysgeusia—Capecitabine—esophageal cancer	0.000136	0.00869	CcSEcCtD
Magnesium salicylate—ALB—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000136	0.00261	CbGpPWpGaD
Magnesium salicylate—Decreased appetite—Cisplatin—esophageal cancer	0.000134	0.00854	CcSEcCtD
Magnesium salicylate—Drowsiness—Methotrexate—esophageal cancer	0.000132	0.00846	CcSEcCtD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000132	0.00253	CbGpPWpGaD
Magnesium salicylate—Pain—Cisplatin—esophageal cancer	0.000132	0.0084	CcSEcCtD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.00013	0.00249	CbGpPWpGaD
Magnesium salicylate—Sweating—Methotrexate—esophageal cancer	0.000127	0.00811	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Cisplatin—esophageal cancer	0.000127	0.0081	CcSEcCtD
Magnesium salicylate—Epistaxis—Methotrexate—esophageal cancer	0.000125	0.00798	CcSEcCtD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—CFL1—esophageal cancer	0.000121	0.00232	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CREBBP—esophageal cancer	0.000119	0.00229	CbGpPWpGaD
Magnesium salicylate—Hepatitis—Methotrexate—esophageal cancer	0.000119	0.00759	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.000119	0.00228	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000119	0.00228	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000118	0.00227	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—esophageal cancer	0.000117	0.00225	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000115	0.0022	CbGpPWpGaD
Magnesium salicylate—Confusional state—Capecitabine—esophageal cancer	0.000114	0.0073	CcSEcCtD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—GNG7—esophageal cancer	0.000114	0.00219	CbGpPWpGaD
Magnesium salicylate—Oedema—Capecitabine—esophageal cancer	0.000113	0.00724	CcSEcCtD
Magnesium salicylate—Carbamazepine—ABCB1—esophageal cancer	0.000113	0.015	CrCbGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000113	0.00217	CbGpPWpGaD
Magnesium salicylate—Erythema multiforme—Methotrexate—esophageal cancer	0.000112	0.00718	CcSEcCtD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000112	0.00216	CbGpPWpGaD
Magnesium salicylate—Shock—Capecitabine—esophageal cancer	0.000112	0.00713	CcSEcCtD
Magnesium salicylate—Tinnitus—Methotrexate—esophageal cancer	0.000111	0.00708	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Capecitabine—esophageal cancer	0.00011	0.007	CcSEcCtD
Magnesium salicylate—Anorexia—Capecitabine—esophageal cancer	0.000108	0.00691	CcSEcCtD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TLR4—esophageal cancer	0.000107	0.00205	CbGpPWpGaD
Magnesium salicylate—Hypotension—Capecitabine—esophageal cancer	0.000106	0.00677	CcSEcCtD
Magnesium salicylate—Diarrhoea—Cisplatin—esophageal cancer	0.000105	0.00672	CcSEcCtD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CDKN2A—esophageal cancer	0.000105	0.00201	CbGpPWpGaD
Magnesium salicylate—Erythema—Methotrexate—esophageal cancer	0.000103	0.00661	CcSEcCtD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—BCL2—esophageal cancer	0.000103	0.00198	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—NOS2—esophageal cancer	0.000101	0.00195	CbGpPWpGaD
Magnesium salicylate—Dysgeusia—Methotrexate—esophageal cancer	0.000101	0.00647	CcSEcCtD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.0001	0.00193	CbGpPWpGaD
Magnesium salicylate—Dyspepsia—Capecitabine—esophageal cancer	9.99e-05	0.00638	CcSEcCtD
Magnesium salicylate—Decreased appetite—Capecitabine—esophageal cancer	9.86e-05	0.0063	CcSEcCtD
Magnesium salicylate—ALB—Hemostasis—ATP1B2—esophageal cancer	9.86e-05	0.00189	CbGpPWpGaD
Magnesium salicylate—Vomiting—Cisplatin—esophageal cancer	9.79e-05	0.00625	CcSEcCtD
Magnesium salicylate—Rash—Cisplatin—esophageal cancer	9.7e-05	0.0062	CcSEcCtD
Magnesium salicylate—Constipation—Capecitabine—esophageal cancer	9.7e-05	0.0062	CcSEcCtD
Magnesium salicylate—Pain—Capecitabine—esophageal cancer	9.7e-05	0.0062	CcSEcCtD
Magnesium salicylate—Dermatitis—Cisplatin—esophageal cancer	9.7e-05	0.00619	CcSEcCtD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	9.57e-05	0.00184	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	9.55e-05	0.00183	CbGpPWpGaD
Magnesium salicylate—Feeling abnormal—Capecitabine—esophageal cancer	9.35e-05	0.00597	CcSEcCtD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	9.3e-05	0.00179	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	9.26e-05	0.00178	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	9.26e-05	0.00178	CbGpPWpGaD
Magnesium salicylate—Nausea—Cisplatin—esophageal cancer	9.14e-05	0.00584	CcSEcCtD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	9.08e-05	0.00174	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—RB1—esophageal cancer	9.07e-05	0.00174	CbGpPWpGaD
Magnesium salicylate—Urticaria—Capecitabine—esophageal cancer	9.01e-05	0.00576	CcSEcCtD
Magnesium salicylate—ALB—Hemostasis—DOCK2—esophageal cancer	8.92e-05	0.00171	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CCND1—esophageal cancer	8.84e-05	0.0017	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	8.76e-05	0.00168	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	8.76e-05	0.00168	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CDKN1A—esophageal cancer	8.55e-05	0.00164	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	8.53e-05	0.00164	CbGpPWpGaD
Magnesium salicylate—Confusional state—Methotrexate—esophageal cancer	8.52e-05	0.00544	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Methotrexate—esophageal cancer	8.16e-05	0.00521	CcSEcCtD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—EP300—esophageal cancer	8.14e-05	0.00156	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	8.09e-05	0.00155	CbGpPWpGaD
Magnesium salicylate—Anorexia—Methotrexate—esophageal cancer	8.05e-05	0.00514	CcSEcCtD
Magnesium salicylate—Pruritus—Capecitabine—esophageal cancer	8.03e-05	0.00513	CcSEcCtD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	7.97e-05	0.00153	CbGpPWpGaD
Magnesium salicylate—Hypotension—Methotrexate—esophageal cancer	7.89e-05	0.00504	CcSEcCtD
Magnesium salicylate—PTGS1—Metabolism—BLVRB—esophageal cancer	7.79e-05	0.0015	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SLC52A3—esophageal cancer	7.79e-05	0.0015	CbGpPWpGaD
Magnesium salicylate—Diarrhoea—Capecitabine—esophageal cancer	7.76e-05	0.00496	CcSEcCtD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—AQP3—esophageal cancer	7.72e-05	0.00148	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PFN1—esophageal cancer	7.7e-05	0.00148	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—PTGS2—esophageal cancer	7.63e-05	0.00146	CbGpPWpGaD
Magnesium salicylate—Somnolence—Methotrexate—esophageal cancer	7.51e-05	0.00479	CcSEcCtD
Magnesium salicylate—Dizziness—Capecitabine—esophageal cancer	7.5e-05	0.00479	CcSEcCtD
Magnesium salicylate—Dyspepsia—Methotrexate—esophageal cancer	7.43e-05	0.00475	CcSEcCtD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	7.4e-05	0.00142	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	7.4e-05	0.00142	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SLC52A3—esophageal cancer	7.38e-05	0.00142	CbGpPWpGaD
Magnesium salicylate—Decreased appetite—Methotrexate—esophageal cancer	7.34e-05	0.00469	CcSEcCtD
Magnesium salicylate—Pain—Methotrexate—esophageal cancer	7.22e-05	0.00461	CcSEcCtD
Magnesium salicylate—Vomiting—Capecitabine—esophageal cancer	7.21e-05	0.00461	CcSEcCtD
Magnesium salicylate—Rash—Capecitabine—esophageal cancer	7.15e-05	0.00457	CcSEcCtD
Magnesium salicylate—Dermatitis—Capecitabine—esophageal cancer	7.15e-05	0.00456	CcSEcCtD
Magnesium salicylate—Headache—Capecitabine—esophageal cancer	7.11e-05	0.00454	CcSEcCtD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—MYC—esophageal cancer	7.09e-05	0.00136	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KMT2D—esophageal cancer	7.04e-05	0.00135	CbGpPWpGaD
Magnesium salicylate—Feeling abnormal—Methotrexate—esophageal cancer	6.96e-05	0.00444	CcSEcCtD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	6.95e-05	0.00134	CbGpPWpGaD
Magnesium salicylate—Nausea—Capecitabine—esophageal cancer	6.74e-05	0.0043	CcSEcCtD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CCND1—esophageal cancer	6.73e-05	0.00129	CbGpPWpGaD
Magnesium salicylate—Urticaria—Methotrexate—esophageal cancer	6.71e-05	0.00428	CcSEcCtD
Magnesium salicylate—PTGS1—Metabolism—SLC10A2—esophageal cancer	6.62e-05	0.00127	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CA1—esophageal cancer	6.62e-05	0.00127	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	6.45e-05	0.00124	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CFL1—esophageal cancer	6.24e-05	0.0012	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	6.22e-05	0.00119	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	6.19e-05	0.00119	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—BLVRB—esophageal cancer	6.18e-05	0.00119	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC52A3—esophageal cancer	6.18e-05	0.00119	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CA2—esophageal cancer	6.05e-05	0.00116	CbGpPWpGaD
Magnesium salicylate—Pruritus—Methotrexate—esophageal cancer	5.98e-05	0.00382	CcSEcCtD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.92e-05	0.00114	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—GNG7—esophageal cancer	5.88e-05	0.00113	CbGpPWpGaD
Magnesium salicylate—Diarrhoea—Methotrexate—esophageal cancer	5.78e-05	0.00369	CcSEcCtD
Magnesium salicylate—ALB—Folate Metabolism—TP53—esophageal cancer	5.71e-05	0.0011	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PLCE1—esophageal cancer	5.63e-05	0.00108	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ADH7—esophageal cancer	5.63e-05	0.00108	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.63e-05	0.00108	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5.61e-05	0.00108	CbGpPWpGaD
Magnesium salicylate—Dizziness—Methotrexate—esophageal cancer	5.59e-05	0.00357	CcSEcCtD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.56e-05	0.00107	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.52e-05	0.00106	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FKBP1A—esophageal cancer	5.46e-05	0.00105	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MYC—esophageal cancer	5.4e-05	0.00104	CbGpPWpGaD
Magnesium salicylate—Vomiting—Methotrexate—esophageal cancer	5.37e-05	0.00343	CcSEcCtD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	5.34e-05	0.00102	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—DOCK2—esophageal cancer	5.34e-05	0.00102	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—WIF1—esophageal cancer	5.34e-05	0.00102	CbGpPWpGaD
Magnesium salicylate—Rash—Methotrexate—esophageal cancer	5.33e-05	0.0034	CcSEcCtD
Magnesium salicylate—Dermatitis—Methotrexate—esophageal cancer	5.32e-05	0.0034	CcSEcCtD
Magnesium salicylate—Headache—Methotrexate—esophageal cancer	5.29e-05	0.00338	CcSEcCtD
Magnesium salicylate—PTGS2—Spinal Cord Injury—EGFR—esophageal cancer	5.28e-05	0.00101	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CA1—esophageal cancer	5.26e-05	0.00101	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC10A2—esophageal cancer	5.26e-05	0.00101	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	5.19e-05	0.000996	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.09e-05	0.000977	CbGpPWpGaD
Magnesium salicylate—Nausea—Methotrexate—esophageal cancer	5.02e-05	0.0032	CcSEcCtD
Magnesium salicylate—ALB—Metabolism—SLC52A3—esophageal cancer	5e-05	0.00096	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—BLVRB—esophageal cancer	5e-05	0.00096	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ADH1B—esophageal cancer	4.94e-05	0.000948	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CSNK1A1—esophageal cancer	4.92e-05	0.000946	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CA2—esophageal cancer	4.81e-05	0.000923	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HSPA5—esophageal cancer	4.79e-05	0.00092	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—TYMP—esophageal cancer	4.72e-05	0.000906	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.7e-05	0.000902	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP26A1—esophageal cancer	4.59e-05	0.000881	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4.58e-05	0.00088	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALOX15—esophageal cancer	4.47e-05	0.000859	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.47e-05	0.000858	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PLCE1—esophageal cancer	4.47e-05	0.000858	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ADH7—esophageal cancer	4.47e-05	0.000858	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	4.44e-05	0.000852	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	4.43e-05	0.000851	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.42e-05	0.000848	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—TPI1—esophageal cancer	4.27e-05	0.000819	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTO1—esophageal cancer	4.27e-05	0.000819	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC10A2—esophageal cancer	4.25e-05	0.000816	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CA1—esophageal cancer	4.25e-05	0.000816	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	4.22e-05	0.00081	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ELMO1—esophageal cancer	4.14e-05	0.000794	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALDOB—esophageal cancer	4.09e-05	0.000785	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—GSTO1—esophageal cancer	4.04e-05	0.000777	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TPI1—esophageal cancer	4.04e-05	0.000777	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GAPDH—esophageal cancer	3.94e-05	0.000756	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ADH1B—esophageal cancer	3.92e-05	0.000752	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CRABP1—esophageal cancer	3.9e-05	0.000749	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CA2—esophageal cancer	3.89e-05	0.000747	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ALDOB—esophageal cancer	3.88e-05	0.000744	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.8e-05	0.00073	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TYMP—esophageal cancer	3.74e-05	0.000719	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—GAPDH—esophageal cancer	3.73e-05	0.000717	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HIST1H2BM—esophageal cancer	3.73e-05	0.000717	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GNG7—esophageal cancer	3.71e-05	0.000713	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.67e-05	0.000706	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP26A1—esophageal cancer	3.64e-05	0.0007	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ADH7—esophageal cancer	3.62e-05	0.000694	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PLCE1—esophageal cancer	3.62e-05	0.000694	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.59e-05	0.00069	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.57e-05	0.000686	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALOX15—esophageal cancer	3.55e-05	0.000682	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ABL1—esophageal cancer	3.55e-05	0.000682	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALDH2—esophageal cancer	3.48e-05	0.000668	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TPI1—esophageal cancer	3.39e-05	0.00065	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTO1—esophageal cancer	3.39e-05	0.00065	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTT1—esophageal cancer	3.31e-05	0.000635	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—XIAP—esophageal cancer	3.3e-05	0.000633	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP2A6—esophageal cancer	3.27e-05	0.000628	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.26e-05	0.000625	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALDOB—esophageal cancer	3.25e-05	0.000623	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ADH1B—esophageal cancer	3.17e-05	0.000609	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GAPDH—esophageal cancer	3.13e-05	0.0006	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.12e-05	0.000599	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.1e-05	0.000595	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ENO1—esophageal cancer	3.1e-05	0.000595	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CRABP1—esophageal cancer	3.1e-05	0.000595	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—B2M—esophageal cancer	3.06e-05	0.000589	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PSME2—esophageal cancer	3.05e-05	0.000587	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PSME1—esophageal cancer	3.05e-05	0.000587	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TYMP—esophageal cancer	3.03e-05	0.000582	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.02e-05	0.00058	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.98e-05	0.000572	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP26A1—esophageal cancer	2.95e-05	0.000566	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GNG7—esophageal cancer	2.95e-05	0.000566	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ENO1—esophageal cancer	2.94e-05	0.000564	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PSME2—esophageal cancer	2.9e-05	0.000556	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PSME1—esophageal cancer	2.9e-05	0.000556	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ALOX15—esophageal cancer	2.87e-05	0.000552	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CALR—esophageal cancer	2.78e-05	0.000534	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALDH2—esophageal cancer	2.76e-05	0.00053	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTO1—esophageal cancer	2.74e-05	0.000526	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TPI1—esophageal cancer	2.74e-05	0.000526	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FBXW7—esophageal cancer	2.69e-05	0.000516	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.67e-05	0.000512	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP1B1—esophageal cancer	2.64e-05	0.000506	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ALDOB—esophageal cancer	2.63e-05	0.000504	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTT1—esophageal cancer	2.63e-05	0.000504	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP2A6—esophageal cancer	2.6e-05	0.000498	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.59e-05	0.000497	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NOS2—esophageal cancer	2.56e-05	0.000491	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GAPDH—esophageal cancer	2.53e-05	0.000486	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CRABP1—esophageal cancer	2.51e-05	0.000481	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP19A1—esophageal cancer	2.48e-05	0.000476	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PTGS1—esophageal cancer	2.46e-05	0.000473	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ENO1—esophageal cancer	2.46e-05	0.000473	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PSME1—esophageal cancer	2.42e-05	0.000466	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PSME2—esophageal cancer	2.42e-05	0.000466	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GNG7—esophageal cancer	2.38e-05	0.000458	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CREBBP—esophageal cancer	2.3e-05	0.000441	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—HMOX1—esophageal cancer	2.26e-05	0.000434	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	2.25e-05	0.000431	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ALDH2—esophageal cancer	2.23e-05	0.000429	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.22e-05	0.000426	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TGFBR2—esophageal cancer	2.17e-05	0.000417	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ABCB1—esophageal cancer	2.17e-05	0.000417	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTT1—esophageal cancer	2.12e-05	0.000408	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP2A6—esophageal cancer	2.1e-05	0.000403	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP1B1—esophageal cancer	2.09e-05	0.000402	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.09e-05	0.000402	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SMAD4—esophageal cancer	2.06e-05	0.000395	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NOS3—esophageal cancer	2.06e-05	0.000395	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ENO1—esophageal cancer	1.99e-05	0.000382	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTGS1—esophageal cancer	1.99e-05	0.000382	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.99e-05	0.000382	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP19A1—esophageal cancer	1.97e-05	0.000378	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PSME2—esophageal cancer	1.96e-05	0.000377	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PSME1—esophageal cancer	1.96e-05	0.000377	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—HMOX1—esophageal cancer	1.79e-05	0.000345	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.76e-05	0.000338	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ABCB1—esophageal cancer	1.72e-05	0.000331	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.71e-05	0.000329	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP1B1—esophageal cancer	1.69e-05	0.000325	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HIF1A—esophageal cancer	1.68e-05	0.000323	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.64e-05	0.000315	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP19A1—esophageal cancer	1.59e-05	0.000306	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—EP300—esophageal cancer	1.56e-05	0.000301	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOS2—esophageal cancer	1.53e-05	0.000294	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOTCH1—esophageal cancer	1.52e-05	0.000291	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—HMOX1—esophageal cancer	1.45e-05	0.000279	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CREBBP—esophageal cancer	1.45e-05	0.000279	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.42e-05	0.000274	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ABCB1—esophageal cancer	1.39e-05	0.000268	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CREBBP—esophageal cancer	1.37e-05	0.000264	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.3e-05	0.00025	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NOS3—esophageal cancer	1.3e-05	0.000249	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOS3—esophageal cancer	1.23e-05	0.000236	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTGS2—esophageal cancer	1.19e-05	0.000228	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CA—esophageal cancer	1.16e-05	0.000222	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CREBBP—esophageal cancer	1.15e-05	0.000221	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ERBB2—esophageal cancer	1.15e-05	0.000221	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TP53—esophageal cancer	1.12e-05	0.000215	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.05e-05	0.000202	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NOS3—esophageal cancer	1.03e-05	0.000198	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—EP300—esophageal cancer	9.88e-06	0.00019	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN1A—esophageal cancer	9.84e-06	0.000189	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EP300—esophageal cancer	9.36e-06	0.00018	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CREBBP—esophageal cancer	9.32e-06	0.000179	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NOS3—esophageal cancer	8.34e-06	0.00016	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MYC—esophageal cancer	8.16e-06	0.000157	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EGFR—esophageal cancer	7.98e-06	0.000153	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—EP300—esophageal cancer	7.84e-06	0.000151	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTGS2—esophageal cancer	7.63e-06	0.000146	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CA—esophageal cancer	7.31e-06	0.00014	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CA—esophageal cancer	6.93e-06	0.000133	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—EP300—esophageal cancer	6.34e-06	0.000122	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CA—esophageal cancer	5.8e-06	0.000111	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CA—esophageal cancer	4.69e-06	9.01e-05	CbGpPWpGaD
